Clinical Trial Update: Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled steroids for early pediatric acute respiratory distress syndrome was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2022-05-31